全文获取类型
收费全文 | 14053篇 |
免费 | 1303篇 |
国内免费 | 203篇 |
专业分类
耳鼻咽喉 | 107篇 |
儿科学 | 288篇 |
妇产科学 | 119篇 |
基础医学 | 2598篇 |
口腔科学 | 316篇 |
临床医学 | 910篇 |
内科学 | 1485篇 |
皮肤病学 | 227篇 |
神经病学 | 463篇 |
特种医学 | 442篇 |
外国民族医学 | 14篇 |
外科学 | 2958篇 |
综合类 | 1259篇 |
预防医学 | 217篇 |
眼科学 | 131篇 |
药学 | 729篇 |
10篇 | |
中国医学 | 189篇 |
肿瘤学 | 3097篇 |
出版年
2024年 | 29篇 |
2023年 | 263篇 |
2022年 | 286篇 |
2021年 | 413篇 |
2020年 | 495篇 |
2019年 | 410篇 |
2018年 | 436篇 |
2017年 | 431篇 |
2016年 | 410篇 |
2015年 | 509篇 |
2014年 | 779篇 |
2013年 | 1070篇 |
2012年 | 590篇 |
2011年 | 723篇 |
2010年 | 591篇 |
2009年 | 650篇 |
2008年 | 604篇 |
2007年 | 627篇 |
2006年 | 598篇 |
2005年 | 496篇 |
2004年 | 471篇 |
2003年 | 434篇 |
2002年 | 410篇 |
2001年 | 382篇 |
2000年 | 342篇 |
1999年 | 380篇 |
1998年 | 300篇 |
1997年 | 295篇 |
1996年 | 246篇 |
1995年 | 253篇 |
1994年 | 211篇 |
1993年 | 189篇 |
1992年 | 165篇 |
1991年 | 127篇 |
1990年 | 123篇 |
1989年 | 102篇 |
1988年 | 86篇 |
1987年 | 88篇 |
1986年 | 77篇 |
1985年 | 95篇 |
1984年 | 88篇 |
1983年 | 50篇 |
1982年 | 64篇 |
1981年 | 47篇 |
1980年 | 40篇 |
1979年 | 22篇 |
1978年 | 26篇 |
1977年 | 13篇 |
1976年 | 8篇 |
1975年 | 5篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
《Diagnostic Histopathology》2022,28(11):493-500
After decades of relative stagnation lung cancer is emerging as a disease type where rapid progress is being made in diagnosis and therapy, as well as in our understanding of disease biology. Much of this progress is of immediate impact to diagnosticians, and more is likely to affect diagnostic practice in the near future. In this review we seek to briefly summarize several key areas of active research of immediate or probable imminent value to trainee and consultant pulmonary pathologists alike. We cover some major changes in tumour classification, grading, and patient stratification, as well as considering the state of the art in machine-assisted interpretation of lung cancer histology, and the use of genetically modified lung cancer models. 相似文献
2.
正目前,临床上对于直肠癌常用的影像评估方法有MRI、螺旋CT、PET-CT、直肠腔内超声(ERUS)等。而MRI作为首选检查方式,对肿瘤位置、浸润深度、淋巴结转移、血管侵犯、环周切缘及周围器官侵犯等方面的评估均具有明显优势~([1-2])。通过MRI诊断淋巴结的方法通常是影像科医师逐层浏览每一幅图像,从中识别淋巴结的形状、界限及密度来判断,这种传统方式耗时较长且存在主观偏倚,导致 相似文献
3.
Can EGFR mutation status be reliably determined in pre‐operative needle biopsies from adenocarcinomas of the lung? 下载免费PDF全文
Kim Hein Lindahl Flemming Brandt Sørensen Søren Peter Jonstrup Karen Ege Olsen Siegfried Loeschke 《APMIS : acta pathologica, microbiologica, et immunologica Scandinavica》2015,123(4):289-297
The identification of EGFR mutations in non‐small‐cell lung cancer is important for selecting patients, who may benefit from treatment with EGFR tyrosine kinase inhibitors. The analysis is usually performed on cytological aspirates and/or histological needle biopsies, representing a small fraction of the tumour volume. The aim of the present investigation was to evaluate the diagnostic performance of this molecular test. We retrospectively included 201 patients with primary adenocarcinoma of the lung. EGFR mutation status (exon 19 deletions and exon 21 L858R point mutation) was evaluated on both pre‐operative biopsies (131 histological and 70 cytological) and on the surgical specimens, using PCR. Samples with low tumour cell fraction were assigned to laser micro‐dissection (LMD). We found nine (4.5%) patients with EGFR mutation in the lung tumour resections, but failed to identify mutation in one of the corresponding pre‐operative, cytological specimens. Several (18.4%) analyses of the pre‐operative biopsies were inconclusive, especially in case of biopsies undergoing LMD and regarding exon 21 analysis. Discrepancy of mutation status in one patient may reflect intra‐tumoural heterogeneity or technical issues. Moreover, several inconclusive results in the diagnostic biopsies reveal that attention must be paid on the suitability of pre‐operative biopsies for EGFR mutation analysis. 相似文献
4.
5.
Pancreatic ductal adenocarcinoma (PDAC) is predicted to become the second leading cause of cancer-related mortality within the next decade, with limited effective treatment options and a dismal long-term prognosis for patients. Genomic profiling has not yet manifested clinical benefits for diagnosis, treatment or prognosis in PDAC, due to the lack of available tissues for sequencing and the confounding effects of low tumour cellularity in many biopsy specimens. Increasing focus is now turning to the use of minimally invasive liquid biopsies to enhance the characterisation of actionable PDAC tumour genomes. Circulating tumour DNA (ctDNA) is the most comprehensively studied liquid biopsy analyte in blood and can provide insight into the molecular profile and biological characteristics of individual PDAC tumours, in real-time and in advance of traditional imaging modalities. This can pave the way for identification of new therapeutic targets, novel risk variants and markers of tumour response, to supplement diagnostic screening and provide enhanced scrutiny in treatment stratification. In the roadmap towards the application of precision medicine for clinical management in PDAC, ctDNA analyses may serve a leading role in streamlining candidate biomarkers for clinical integration. In this review, we highlight recent developments in the use of ctDNA-based liquid biopsies for PDAC and provide new insights into the technical, analytical and biological challenges that must be overcome for this potential to be realised. 相似文献
6.
7.
目的:研究全麻复合硬膜外在高龄患者腹腔镜直肠癌根治术中的应用效果。方法:选择60岁以上择期行腹腔镜直肠癌根治术患者60例,随机分为G组和GA组,每组各30例。G组患者为单纯全麻组,GA组患者为硬膜外复合全麻组。GA组患者在诱导前取L1~2硬膜外穿刺置管,予0.5%罗哌卡因5 ml,术中每小时追加5~7 ml。两组患者诱导方法相同:即,咪哒唑仑0.04 mg/kg、舒芬太尼0.3~0.4μg/kg、顺阿曲库铵0.15~0.20 mg/kg、依托咪酯0.2~0.3 mg/kg。监测并记录患者血压(BP),心率(HR),心电图(ECG),术中全麻药用量及术后患者苏醒情况。结果:GA组患者气腹后、拔管前BP、HR明显低于G组(P<0.05),且全麻药用量明显低于G组(P<0.05)。结论:全麻复合硬膜外应用于老年腹腔镜直肠癌手术较单纯全麻用药量减少,术中循环更加稳定,是腹腔镜直肠癌根治术比较安全可行的麻醉方法。 相似文献
8.
《Clínica e investigación en ginecología y obstetricia》2022,49(2):100721
Intravascular papillary endothelial hyperplasia or Masson's tumour is a non-neoplastic vascular lesion of reactive character. It is a rare diagnosis, clinically non-specific and with diverse locations. It is essential to take it into consideration and make a differential diagnosis with malignant vascular tumours such as angiosarcoma. Pathological study is fundamental for diagnosis. Treatment consists of complete resection of the tumour, including sufficiently wide margins to avoid recurrence.The case reported is an exceptional event, because of the pelvic location of the Masson's tumour that was diagnosed as part of the surgical staging of an ovarian cancer. 相似文献
9.